Results for hartkapseln pirfenidon 267 mg translation from German to English

Computer translation

Trying to learn how to translate from the human translation examples.

German

English

Info

German

hartkapseln pirfenidon 267 mg

English

 

From: Machine Translation
Suggest a better translation
Quality:

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

German

English

Info

German

esbriet 267 mg hartkapseln pirfenidon

English

esbriet 267 mg hard capsules pirfenidone

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

German

esbriet 267 mg hartkapseln

English

esbriet 267 mg hard capsules

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

German

jede kapsel enthält 267 mg pirfenidon.

English

each capsule contains 267 mg of pirfenidone.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

German

es ist als kapseln (267 mg) erhältlich.

English

it is available as capsules (267 mg).

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

German

die ergebnisse zeigten bei patienten mit mittelschwerer leberfunktionsstörung nach einer einzeldosis von 801 mg pirfenidon (3 x 267-mg-kapsel) eine mittlere zunahme der pirfenidon-exposition von 60 %.

English

results showed that there was a mean increase of 60% in pirfenidone exposure after a single dose of 801 mg pirfenidone (3 x 267 mg capsule) in patients with moderate hepatic impairment.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

German

die empfohlene tagesdosis von esbriet für patienten mit ipf beträgt drei 267-mg-kapseln dreimal täglich zusammen mit nahrung, sodass die gesamtdosis 2.403 mg/tag beträgt.

English

the recommended daily dose of esbriet for patients with ipf is three 267 mg capsules three times a day with food for a total of 2403 mg/day.

Last Update: 2017-04-26
Usage Frequency: 1
Quality:

Get a better translation with
7,727,850,393 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK